RBC Capital Maintains Outperform on Johnson & Johnson, Raises Price Target to $181
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Shagun Singh has maintained an Outperform rating on Johnson & Johnson (NYSE:JNJ) and increased the price target from $178 to $181.
December 06, 2023 | 3:53 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
RBC Capital analyst Shagun Singh maintains an Outperform rating on Johnson & Johnson and raises the price target from $178 to $181.
The increase in price target by RBC Capital suggests a positive outlook on Johnson & Johnson's stock, which could lead to increased investor confidence and a potential rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100